Lord, Abbett & Co. LLC
- SEC CIK
- 0000728100
- Latest filing
- Aug 14, 2026
KRYS holding history
Krystal Biotech, Inc. in every 13F filed by Lord, Abbett & Co. LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
KRYS overviewAll 13F holders of KRYSFull Q2 2026 holdings
- Shares (Q2 2025)
- 0
- Sold out in Q2 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 17
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2025 | 0 | $0 | 0.0% | −151,225−100.0% | Sold out | Holders |
| Q1 2025 | 151,225 | $27.3M | 0.1% | −64,403−29.9% | Reduced | Holders |
| Q4 2024 | 215,628 | $33.8M | 0.1% | −68,531−24.1% | Reduced | Holders |
| Q3 2024 | 284,159 | $51.7M | 0.2% | −108,079−27.6% | Reduced | Holders |
| Q2 2024 | 392,238 | $72.0M | 0.2% | −99,994−20.3% | Reduced | Holders |
| Q1 2024 | 492,232 | $87.6M | 0.3% | −126,226−20.4% | Reduced | Holders |
| Q4 2023 | 618,458 | $76.7M | 0.3% | −52,853−7.9% | Reduced | Holders |
| Q3 2023 | 671,311 | $77.9M | 0.3% | −171,337−20.3% | Reduced | Holders |
| Q2 2023 | 842,648 | $98.9M | 0.3% | −118,594−12.3% | Reduced | Holders |
| Q1 2023 | 961,242 | $77.0M | 0.3% | −316,780−24.8% | Reduced | Holders |
| Q4 2022 | 1,278,022 | $101.2M | 0.4% | +66,081+5.5% | Added | Holders |
| Q3 2022 | 1,211,941 | $84.5M | 0.3% | +94,375+8.4% | Added | Holders |
| Q2 2022 | 1,117,566 | $73.4M | 0.3% | −61,247−5.2% | Reduced | Holders |
| Q1 2022 | 1,178,813 | $78.4M | 0.2% | +4,950+0.4% | Added | Holders |
| Q4 2021 | 1,173,863 | $82.1M | 0.2% | +106,705+10.0% | Added | Holders |
| Q3 2021 | 1,067,158 | $55.7M | 0.1% | −124,422−10.4% | Reduced | Holders |
| Q2 2021 | 1,191,580 | $81.0M | 0.2% | −194,063−14.0% | Reduced | Holders |
| Q1 2021 | 1,385,643 | $106.8M | 0.3% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.